As I read further into the very long article, I think we as a society should consider statutory / compulsory licensing for medical patents, especially drugs. In Europe they limit prescription drug prices to a certain profit margin. This is again "cost plus" pricing that reduces the prices relative to what we pay in the states.
It may raise everyone's costs however, because this "cost plus" regulation incents manufacturers to increase costs to increase profits.
Statutory licensing would do the opposite: allow companies to compete with patent holders on efficiency of manufacturing while creating a mechanism to repay R&D.
It may raise everyone's costs however, because this "cost plus" regulation incents manufacturers to increase costs to increase profits.
Statutory licensing would do the opposite: allow companies to compete with patent holders on efficiency of manufacturing while creating a mechanism to repay R&D.